{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:51:32Z","timestamp":1783353092510,"version":"3.54.6"},"reference-count":25,"publisher":"CSIRO Publishing","issue":"2","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":867,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective and importance of study:<\/jats:title>\n                    <jats:p>Risk-stratified approaches to cancer screening aim to provide tailored risk advice to individuals, rather than the mostly one-size-fits-all approach designed for the average person that is currently used in Australia. Stratified cancer screening has the potential to increase the benefits and reduce the harms of screening. Initial risk assessment is a crucial first step for screening programs that use risk stratification. We report findings from a qualitative study exploring the views of the Australian public on how to best deliver risk-stratified cancer screening in the population to help inform future implementation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study type:<\/jats:title>\n                    <jats:p>Qualitative interview study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted semistructured interviews with participants from a previous study, half of whom had received personal genomic risk information and half of whom had not. We asked how and where they would like to see risk-stratified screening delivered and how they felt about different health professionals assessing their cancer risk. Data were analysed thematically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Forty interviews were conducted. The age range of participants was 21\u201368 years; 58% were female. Themes included: 1) Convenience is a priority; 2) General practice is a good fit for some; 3) Web-based technology is part of the process; and 4) \"I would want to know why [I was being stratified]\". Similar views were expressed by both groups. Our findings suggest that although health professionals were identified as having an important role, there were mixed preferences for delivery by general practitioners, medical specialists or nurses. Participants were less concerned about who undertook the risk assessment than whether the health professional had the appropriate skill set and availability. Clear communication and evidence of the need for change in screening eligibility and frequency were key factors in the successful delivery of risk-stratified screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We identified that convenience and good communication, including clear explanations to the public with convincing evidence for change, will enable the successful delivery of risk-stratified cancer screening in the population, including organised and opportunistic screening approaches. Health professional education and upskilling across disciplines will be key facilitators. Engagement and further consultation with primary care and other key stakeholders will be central.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.17061\/phrp32232213","type":"journal-article","created":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T19:27:00Z","timestamp":1662319620000},"source":"Crossref","is-referenced-by-count":7,"title":["Views of the Australian public on the delivery of risk-stratified cancer screening in the population: a qualitative study"],"prefix":"10.1071","volume":"33","author":[{"given":"Kate","family":"Dunlop","sequence":"first","affiliation":[{"name":"A Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia"},{"name":"B Melanoma Institute Australia, University of Sydney, NSW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Rankin","sequence":"additional","affiliation":[{"name":"C Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Smit","sequence":"additional","affiliation":[{"name":"A Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia"},{"name":"B Melanoma Institute Australia, University of Sydney, NSW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainsley","family":"Newson","sequence":"additional","affiliation":[{"name":"D Sydney Health Ethics, Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Keogh","sequence":"additional","affiliation":[{"name":"E Centre for Health Equity, Melbourne School of Population and Global Health, University of Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cust","sequence":"additional","affiliation":[{"name":"A Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia"},{"name":"B Melanoma Institute Australia, University of Sydney, NSW"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"2026011323070451300_R1","doi-asserted-by":"crossref","unstructured":"Glasziou PP, Jones MA, Pathirana T, Barratt AL, Bell KJ. Estimating the magnitude of cancer overdiagnosis in Australia. Med J Aust. 2020;212(4):163\u20138. CrossRef | PubMed","DOI":"10.5694\/mja2.50455"},{"key":"2026011323070451300_R2","doi-asserted-by":"crossref","unstructured":"Long H, Brooks JM, Harvie M, Maxwell A, French DP. How do women experience a false-positive test result from breast screening? A systematic review and thematic synthesis of qualitative studies. Br J Cancer. 2019;121(4):351\u20138. CrossRef | PubMed","DOI":"10.1038\/s41416-019-0524-4"},{"key":"2026011323070451300_R3","doi-asserted-by":"crossref","unstructured":"Marcus PM, Pashayan N, Church TR, Doria-Rose VP, Gould MK, Hubbard RA, et al. Population-based precision cancer screening: a symposium on evidence, epidemiology, and next steps. Cancer Epidemiol Biomarkers Prev. 2016;25(11):1449\u201355. CrossRef | PubMed","DOI":"10.1158\/1055-9965.EPI-16-0555"},{"key":"2026011323070451300_R4","doi-asserted-by":"crossref","unstructured":"Allweis TM, Hermann N, Berenstein-Molho R, Guindy M. Personalized screening for breast cancer: rationale, present practices, and future directions. Ann Surg Oncol. 2021;28(8):4306\u201317. CrossRef | PubMed","DOI":"10.1245\/s10434-020-09426-1"},{"key":"2026011323070451300_R5","doi-asserted-by":"crossref","unstructured":"Smit AK, Allen M, Beswick B, Butow P, Dawkins H, Dobbinson SJ, et al. Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial. Genet Med. 202;23(12): 2394\u20132403. CrossRef | PubMed","DOI":"10.1038\/s41436-021-01292-w"},{"key":"2026011323070451300_R6","doi-asserted-by":"crossref","unstructured":"Knoppers BM, Bernier A, Granados Moreno P, Pashayan N. Of screening, stratification, and scores. J Pers Med. 2021;11(8):736. CrossRef | PubMed","DOI":"10.3390\/jpm11080736"},{"key":"2026011323070451300_R7","doi-asserted-by":"crossref","unstructured":"Pashayan N, Morris S, Gilbert FJ, Pharoah PDP. Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast cancer: a life-table model. JAMA Oncol. 2018;4(11):1504\u201310. CrossRef | PubMed","DOI":"10.1001\/jamaoncol.2018.1901"},{"key":"2026011323070451300_R8","doi-asserted-by":"crossref","unstructured":"Subramanian S, Bobashev G, Morris RJ, Hoover S. Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost? Cancer Causes Control. 2017;28(4):299\u2013308. CrossRef | PubMed","DOI":"10.1007\/s10552-017-0864-4"},{"key":"2026011323070451300_R9","doi-asserted-by":"crossref","unstructured":"Sondak VK, Glass LF, Geller AC. Risk-stratified screening for detection of melanoma. JAMA. 2015;313(6):616\u20137. CrossRef | PubMed","DOI":"10.1001\/jama.2014.13813"},{"key":"2026011323070451300_R10","doi-asserted-by":"crossref","unstructured":"Pashayan N, Duffy SW, Neal DE, Hamdy FC, Donovan JL, Martin RM, et al. Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis. Genet Med. 2015;17(10):789\u201395. CrossRef | PubMed","DOI":"10.1038\/gim.2014.192"},{"key":"2026011323070451300_R11","doi-asserted-by":"crossref","unstructured":"Mbuya Bienge C, Pashayan N, Brooks JD, Dorval M, Chiquette J, Eloy L, et al. Women's views on multifactorial breast cancer risk assessment and risk-stratified screening: a population-based survey from four provinces in Canada. J Pers Med. 2021;11(2):95. CrossRef | PubMed","DOI":"10.3390\/jpm11020095"},{"key":"2026011323070451300_R12","doi-asserted-by":"crossref","unstructured":"Lippey J, Keogh LA, Mann GB, Campbell IG, Forrest LE. \"A natural progression\": Australian women's attitudes about an individualized breast screening model. Cancer Prev Res. 2019;12(6):383\u201390. CrossRef | PubMed","DOI":"10.1158\/1940-6207.CAPR-18-0443"},{"key":"2026011323070451300_R13","doi-asserted-by":"crossref","unstructured":"Dunlop K, Rankin NM, Smit AK, Salgado Z, Newson AJ, Keogh L, et al. Acceptability of risk-stratified population screening across cancer types: qualitative interviews with the Australian public. Health Expect. 2021;24(4):1326\u201336. CrossRef | PubMed","DOI":"10.1111\/hex.13267"},{"key":"2026011323070451300_R14","doi-asserted-by":"crossref","unstructured":"Puzhko S, Gagnon J, Simard J, Knoppers BM, Siedlikowski S, Bartlett G. Health professionals' perspectives on breast cancer risk stratification: understanding evaluation of risk versus screening for disease. Public Health Rev. 2019;40:2. CrossRef | PubMed","DOI":"10.1186\/s40985-019-0111-5"},{"key":"2026011323070451300_R15","doi-asserted-by":"crossref","unstructured":"Evans DG, Howell A. Can the breast screening appointment be used to provide risk assessment and prevention advice? Breast Cancer Res. 2015;17(1):84. CrossRef | PubMed","DOI":"10.1186\/s13058-015-0595-y"},{"key":"2026011323070451300_R16","doi-asserted-by":"crossref","unstructured":"Walker JG, Bickerstaffe A, Hewabandu N, Maddumarachchi S, Dowty JG, CRECRC, et al. The CRISP colorectal cancer risk prediction tool: an exploratory study using simulated consultations in Australian primary care. BMC Med Inform Decis Mak. 2017;17(1):13. CrossRef | PubMed","DOI":"10.1186\/s12911-017-0407-7"},{"key":"2026011323070451300_R17","doi-asserted-by":"crossref","unstructured":"Keogh LA, Steel E, Weideman P, Butow P, Collins IM, Emery JD, et al. Consumer and clinician perspectives on personalising breast cancer prevention information. Breast. 2019;43:39\u201347. CrossRef | PubMed","DOI":"10.1016\/j.breast.2018.11.002"},{"key":"2026011323070451300_R18","doi-asserted-by":"crossref","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77\u2013101. CrossRef","DOI":"10.1191\/1478088706qp063oa"},{"key":"2026011323070451300_R19","doi-asserted-by":"crossref","unstructured":"Rainey L, van der Waal D, Wengstrom Y, Jervaeus A, Broeders MJM. Women's perceptions of the adoption of personalised risk-based breast cancer screening and primary prevention: a systematic review. Acta Oncol. 2018;57(10):1275\u201383. CrossRef | PubMed","DOI":"10.1080\/0284186X.2018.1481291"},{"key":"2026011323070451300_R20","doi-asserted-by":"crossref","unstructured":"Woof VG, McWilliams L, Donnelly LS, Howell A, Evans DG, Maxwell AJ, French DP. Introducing a low-risk breast screening pathway into the NHS breast screening programme: views from healthcare professionals who are delivering risk-stratified screening. Womens Health (Lond). 2021;17:17455065211009746. CrossRef","DOI":"10.1177\/17455065211009746"},{"key":"2026011323070451300_R21","doi-asserted-by":"crossref","unstructured":"Alblas M, Schermer M, Vergouwe Y, Bolt I. Autonomy challenges in epigenetic risk-stratified cancer screening: how can patient decision aids support informed consent? J Pers Med. 2019;9(1):14. CrossRef | PubMed","DOI":"10.3390\/jpm9010014"},{"key":"2026011323070451300_R22","doi-asserted-by":"crossref","unstructured":"Rainey L, van der Waal D, Jervaeus A, Donnelly LS, Evans DG, Hammarstrom M, et al. European women's perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study. BMC Cancer. 2020;20(1):247. CrossRef | PubMed","DOI":"10.1186\/s12885-020-06745-0"},{"key":"2026011323070451300_R23","unstructured":"Australian Institute of Health and Welfare. Cancer screening. Canberra: AIHW; 2020 [cited 2021 Oct 19] Available from: www.aihw.gov.au\/reports\/australias-health\/cancer-screening-and-treatment"},{"key":"2026011323070451300_R24","doi-asserted-by":"crossref","unstructured":"Dawson G, Crane M, Lyons C, Burnham A, Bowman T, Perez D, Travaglia J. General practitioners' perceptions of population based bowel screening and their influence on practice: a qualitative study. BMC Fam Pract. 2017;18(1):36. 28298185 PMCid:PMC5353863 CrossRef | PubMed","DOI":"10.1186\/s12875-017-0610-8"},{"key":"2026011323070451300_R25","doi-asserted-by":"crossref","unstructured":"Taylor A, Caffery LJ, Gesesew HA, King A, Bassal AR, Ford K, et al. How Australian health care services adapted to telehealth during the COVID-19 pandemic: a survey of telehealth professionals. Front Public Health. 2021;9:648009. CrossRef | PubMed","DOI":"10.3389\/fpubh.2021.648009"}],"container-title":["Public Health Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/pu\/article-pdf\/doi\/10.17061\/phrp32232213\/1822270\/pu19424.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/pu\/article-pdf\/doi\/10.17061\/phrp32232213\/1822270\/pu19424.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T04:07:14Z","timestamp":1768363634000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/pu\/article\/33\/2\/e32232213\/265393\/Views-of-the-Australian-public-on-the-delivery-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,7,5]]}},"URL":"https:\/\/doi.org\/10.17061\/phrp32232213","relation":{},"ISSN":["2204-2091"],"issn-type":[{"value":"2204-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"article-number":"e32232213"}}